Uric acid as a prognostic factor and critical marker of COVID-19
Abstract The purpose of this study is to explore whether uric acid (UA) can independently act as a prognostic factor and critical marker of the 2019 novel corona virus disease (COVID-19). A multicenter, retrospective, and observational study including 540 patients with confirmed COVID-19 was carried...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a8e8859d800d4fcea4e7072829e594b2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a8e8859d800d4fcea4e7072829e594b2 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a8e8859d800d4fcea4e7072829e594b22021-12-02T18:03:06ZUric acid as a prognostic factor and critical marker of COVID-1910.1038/s41598-021-96983-42045-2322https://doaj.org/article/a8e8859d800d4fcea4e7072829e594b22021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-96983-4https://doaj.org/toc/2045-2322Abstract The purpose of this study is to explore whether uric acid (UA) can independently act as a prognostic factor and critical marker of the 2019 novel corona virus disease (COVID-19). A multicenter, retrospective, and observational study including 540 patients with confirmed COVID-19 was carried out at four designated hospitals in Wuhan. Demographic, clinical, laboratory data were collected and analyzed. The primary end point was in-hospital death of patients with COVID-19. The concentration of admission UA (adUA) and the lowest concentration of uric acid during hospitalization (lowUA) in the dead patients were significantly lower than those in the survivors. Multivariate logistic regression analysis showed the concentration of lowUA (OR 0.986, 95% CI 0.980–0.992, p < 0.001) was able to independently predict the risk of in-hospital death. The mean survival time in the low-level group of lowUA was significantly lower than other groups. When lowUA was ≤ 166 µmol/L, the sensitivity and specificity in predicting hospital short-term mortality were 76.9%, (95% CI 68.5–85.1%) and 74.9% (95% CI 70.3–78.9%). This retrospective study determined that the lowest concentration of UA during hospitalization can be used as a prognostic indicator and a marker of disease severity in severe patients with COVID-19.Gang LiXia WuChen-liang ZhouYe-ming WangBin SongXiao-bin ChengQiu-fen DongLiu-lin WangSha-sha YouYuan-ming BaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Gang Li Xia Wu Chen-liang Zhou Ye-ming Wang Bin Song Xiao-bin Cheng Qiu-fen Dong Liu-lin Wang Sha-sha You Yuan-ming Ba Uric acid as a prognostic factor and critical marker of COVID-19 |
description |
Abstract The purpose of this study is to explore whether uric acid (UA) can independently act as a prognostic factor and critical marker of the 2019 novel corona virus disease (COVID-19). A multicenter, retrospective, and observational study including 540 patients with confirmed COVID-19 was carried out at four designated hospitals in Wuhan. Demographic, clinical, laboratory data were collected and analyzed. The primary end point was in-hospital death of patients with COVID-19. The concentration of admission UA (adUA) and the lowest concentration of uric acid during hospitalization (lowUA) in the dead patients were significantly lower than those in the survivors. Multivariate logistic regression analysis showed the concentration of lowUA (OR 0.986, 95% CI 0.980–0.992, p < 0.001) was able to independently predict the risk of in-hospital death. The mean survival time in the low-level group of lowUA was significantly lower than other groups. When lowUA was ≤ 166 µmol/L, the sensitivity and specificity in predicting hospital short-term mortality were 76.9%, (95% CI 68.5–85.1%) and 74.9% (95% CI 70.3–78.9%). This retrospective study determined that the lowest concentration of UA during hospitalization can be used as a prognostic indicator and a marker of disease severity in severe patients with COVID-19. |
format |
article |
author |
Gang Li Xia Wu Chen-liang Zhou Ye-ming Wang Bin Song Xiao-bin Cheng Qiu-fen Dong Liu-lin Wang Sha-sha You Yuan-ming Ba |
author_facet |
Gang Li Xia Wu Chen-liang Zhou Ye-ming Wang Bin Song Xiao-bin Cheng Qiu-fen Dong Liu-lin Wang Sha-sha You Yuan-ming Ba |
author_sort |
Gang Li |
title |
Uric acid as a prognostic factor and critical marker of COVID-19 |
title_short |
Uric acid as a prognostic factor and critical marker of COVID-19 |
title_full |
Uric acid as a prognostic factor and critical marker of COVID-19 |
title_fullStr |
Uric acid as a prognostic factor and critical marker of COVID-19 |
title_full_unstemmed |
Uric acid as a prognostic factor and critical marker of COVID-19 |
title_sort |
uric acid as a prognostic factor and critical marker of covid-19 |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/a8e8859d800d4fcea4e7072829e594b2 |
work_keys_str_mv |
AT gangli uricacidasaprognosticfactorandcriticalmarkerofcovid19 AT xiawu uricacidasaprognosticfactorandcriticalmarkerofcovid19 AT chenliangzhou uricacidasaprognosticfactorandcriticalmarkerofcovid19 AT yemingwang uricacidasaprognosticfactorandcriticalmarkerofcovid19 AT binsong uricacidasaprognosticfactorandcriticalmarkerofcovid19 AT xiaobincheng uricacidasaprognosticfactorandcriticalmarkerofcovid19 AT qiufendong uricacidasaprognosticfactorandcriticalmarkerofcovid19 AT liulinwang uricacidasaprognosticfactorandcriticalmarkerofcovid19 AT shashayou uricacidasaprognosticfactorandcriticalmarkerofcovid19 AT yuanmingba uricacidasaprognosticfactorandcriticalmarkerofcovid19 |
_version_ |
1718378828648153088 |